Insulet Corp (NAS:PODD)
$ 199.42 2.91 (1.48%) Market Cap: 13.97 Bil Enterprise Value: 14.41 Bil PE Ratio: 60.40 PB Ratio: 17.65 GF Score: 84/100

Insulet Corp at Nasdaq Investor Conference Transcript

Dec 05, 2023 / 03:00PM GMT
Release Date Price: $191.14 (-1.47%)
Patrick Wood

Amazing. Perfect. Well, hopefully, everyone can hear me. Welcome. This is Patrick Wood. I run the U.S. med tech team. I'm thrilled to have Lauren Budden here, who's the CFO of Insulet; and Deb Gordon, who runs IR and Communications, what should be, I think, a fun back and forth, talking about an exciting time for the company. And so I think why don't we just hop straight into Q&A, if that works?

Lauren Budden
Insulet Corporation - Group VP, CAO, Controller & Interim CFO and Treasurer

Sure.

Questions & Answers

Patrick Wood

Amazing. Maybe if we start -- and unsure how familiar some of the audience are with some of the topics, it might be worth going over them. But O5, Omnipod 5, big, new product for you guys, great adoption in Q3. How are you thinking about the success of that platform and the movement into 2024?

Lauren Budden
Insulet Corporation - Group VP, CAO, Controller & Interim CFO and Treasurer

Yes. So thanks, Patrick. Omnipod 5, we've been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot